Jennison Associates’s Axogen AXGN Stock Holding History

Jennison Associates’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-814,505	Closed	-$16.6M	–	637
2018 Q4	$16.6M	Sell	814,505 -46,885	-5%	-$1.47M	0.02%	378
2018 Q3	$31.7M	Buy	861,390 +485,754	+129%	+$21.2M	0.03%	329
2018 Q2	$18.9M	Buy	375,636 +364,928	+3,408%	+$16.1M	0.02%	411
2018 Q1	$391K	Buy	+10,708	New	+$328K	﹤0.01%	617

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jennison Associates's AXGN Position: Q1 2019 in Review

Jennison Associates sold out of Axogen (AXGN) in Q1 2019, closing a stake of 814,505 shares — an estimated $16.6M sold.

Jennison Associates first reported a position in AXGN in Q1 2018 and held it in 4 quarters. The position peaked at $31.7M in Q3 2018. 141 funds tracked by Wall St. Rank hold AXGN as of Q1 2019.

Jennison Associates reported no remaining Axogen position as of Q1 2019 after selling out during the quarter.
Jennison Associates sold 814,505 Axogen shares in Q1 2019, an estimated $16.6M.
Jennison Associates first reported a position in Axogen in Q1 2018 and held it in 4 quarters.
Jennison Associates's Axogen position peaked at $31.7M in Q3 2018.
141 funds tracked by Wall St. Rank held Axogen as of Q1 2019.

Based on Jennison Associates's 13F filing for Q1 2019, filed 10 May 2019.